Dec 29, 2009 4:04 PM by Rob Kirkpatrick
NEW YORK (AP) - Johnson & Johnson is expanding a voluntary
recall of Tylenol Arthritis Caplets due to consumer reports of a
moldy smell that can cause nausea and sickness.
According to a statement posted to the Food and Drug
Administration Web site late Monday, the New Brunswick, N.J.,
company is now recalling all product lots of the Arthritis Pain
Caplet 100 count bottles with the red EZ-Open Cap.
Johnson & Johnson had recalled five lots of the product last
month after consumers complained of a musty, mildew-like odor that
triggered nausea, stomach pain, vomiting and diarrhea.
The health care company said the odor results from trace amounts
of a chemical called 2,4,6-tribromoanisole. That chemical is
believed to result from the breakdown of another chemical used to
treat wooden pallets that transport and store packaging materials.
To date, the side effects, which also include vomiting and
diarrhea, have been "temporary and non-serious," although the
health effects of the compound have not been studied.
The recall only affects the specific lots cited. All other
Tylenol Arthritis pain products remain available.
The company will reintroduce Tylenol Arthritis Pain Caplets 100
count by January after moving production to a new facility.
J&J's McNeil consumer health care division sells a range of
over-the-counter medicines, including cold reliever Sudafed and the
antacid Mylanta. The unit posted $16 billion in sales in 2008,
according to J&J's annual report.
Consumers seeking a refund or replacement can call J&J at
Company shares rose 38 cents to $65.32 in morning trading